# Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

> **NCT00651846** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 43 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Yasmin (DRSP 3mg/EE 0.03 mg)
- **DRUG:** Microgynon (LNG 0.15 mg/EE 0.03 mg)

## Key facts

- **NCT ID:** NCT00651846
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651846, "Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00651846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*